Gliclazide MR

DRUG4 trials

Sponsors

University of Dundee, Ankara University, Centro de Diabetes Curitiba Ltda

Conditions

Diabetes Mellitus, Type 2MenopauseOsteopeniaOsteoporosisType 2 Diabetes Mellitus

Phase 4

Response To Oral Agents in Diabetes (ROAD)- Pilot Study

CompletedNCT00780715

University of DundeeDiabetes Mellitus, Type 2

Start: 2008-12-31End: 2009-10-31Updated: 2017-10-26

Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability

CompletedNCT01679899

Centro de Diabetes Curitiba LtdaMenopause, Osteopenia, Osteoporosis +1

Start: 2012-12-31End: 2015-10-31Updated: 2016-11-04

Effect of Anti-diabetic Drugs on Glycemic Variability

CompletedNCT02925559

Centro de Diabetes Curitiba LtdaDiabetes Mellitus, Type 2

Start: 2016-10-31End: 2019-01-31Updated: 2020-03-04

Unknown Phase

The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 Diabetes

CompletedNCT01420692

Ankara UniversityType 2 Diabetes Mellitus

Start: 2010-06-30End: 2012-06-30Updated: 2012-08-14

Related Papers

Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial.

2017-05-1516 citations

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01